Form4insider filings, from the source

SEC Form 4 · accession 0001209191-17-001159

ImmunityBio, Inc. · IBRX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Patrick Soon-Shiong
Officer — Chairman and CEO · Director · 10% Owner
Period of report
Dec 30, 2016
Accepted (ET)
Jan 4, 2017 · 5:11 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001326110

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF2Dec 30, 2016G450,000$0.00D40,556,557ISee footnote
Common StockF3holding———5,618,326ISee footnote
Common StockF4holding———600,000D

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses